Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope.
Jedd D
JD
Wolchok
Paul B
PB
Chapman
D001216:Asparagine / Q000378:metabolism; D001224:Aspartic Acid / Q000378:metabolism; D017321:Clinical Trials, Phase I as Topic; D003062:Codon; D003641:Deamination; D018984:Epitopes, T-Lymphocyte / Q000276:immunology*; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D008545:Melanoma / Q000201:enzymology / Q000276:immunology / Q000628:therapy*; D014442:Monophenol Monooxygenase / Q000235:genetics* / Q000276:immunology*; D009363:Neoplasm Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D011499:Protein Processing, Post-Translational / Q000235:genetics; D017422:Sequence Analysis, DNA; D013601:T-Lymphocytes / Q000201:enzymology / Q000276:immunology / Q000378:metabolism* / Q000637:transplantation*; D014182:Transplantation, Autologous
D003062:Codon; D018984:Epitopes, T-Lymphocyte; D009363:Neoplasm Proteins; D001224:Aspartic Acid; D001216:Asparagine; D014442:Monophenol Monooxygenase